Diabetes Monitoring Devices Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Diabetes

Diabetes Monitoring Devices Market


Diabetes monitoring devices are used for tracking glucose levels in diabetic patients. Some of the common diabetes monitoring devices include blood glucose meters, continuous glucose monitoring systems, smart insulin pens, and diabetes apps. Blood glucose meters are portable devices that are used to test blood glucose levels via a small blood sample from the fingertip. 

Continuous glucose monitoring systems (CGM) provide frequent interstitial fluid glucose level readings through a small sensor inserted under the skin. These real-time glucose monitoring systems have become increasingly popular for managing diabetes. Smart insulin pens help manage insulin injections by recording dose details which can be reviewed by patients and healthcare providers. Diabetes management apps allow tracking of glucose readings, carbohydrate intake, insulin doses and other factors.

Diabetes Monitoring Devices Market Growth is estimated to be valued at US$ 73.35 Mn in 2024 and is expected to exhibit a CAGR of 1.0% over the forecast period 2024 to 2030.

Rising prevalence of diabetes due to obesity, sedentary lifestyles and genetic factors has been a major driver of market growth. Self-monitoring of blood glucose levels helps manage diabetes better and reduce complications. Increasing awareness about diabetes self-management and greater acceptance of advanced monitoring technologies are further fueling demand. Healthcare providers also recommend monitoring devices to high risk patients.

Key Takeaways

Key players operating in the Diabetes Monitoring Devices Market are Roche Diagnostics; Thermo Fisher Scientific, Inc.; Eisai Co. Ltd.; Novartis AG; Element Biosciences, Inc.; Dovetail Genomics LLC; Illumina, Inc.; ValiRx Plc.; Abcam plc. Major players are focusing on developing novel integrated diabetes management platforms consisting of CGM systems, insulin pumps, and diabetes management apps. Key players are also expanding their product portfolios and geographic presence through mergers and acquisitions.

The global Diabetes Monitoring Devices Market offers significant growth opportunities due to rising diabetes incidence. Launch of innovative easy to use monitoring devices along with smartphone connectivity will drive wider adoption. Continuous glucose monitoring systems segment is expected to witness highest growth, supported by improving reimbursement scenarios and patient willingness to pay for improved management.

North America represents the largest market for diabetes monitoring devices due to presence of major players, high healthcare expenditure, and supportive regulatory environment. However, Asia Pacific region is anticipated to exhibit fastest growth during the forecast period led by expanding medical infrastructure, growing medical tourism industry and large diabetic population in countries such as China and India. Players are focusing on emerging Asian markets by lowering device prices and adopting innovative business models.

Market Drivers:

- Rising prevalence of diabetes: Growing incidence of diabetes owing to lifestyle changes, obesity and aging population has been a key driver of demand. Around 463 million people worldwide had diabetes in 2019 according to WHO estimates, and this is anticipated to increase substantially in coming years.

- Increasing healthcare expendititure: Higher healthcare spending globally has enabled greater access to advanced diabetes management technologies like continuous glucose monitoring systems. This coupled with growing reimbursement support is positively impacting market growth.

Market Restrains:

- High device costs: Continuous glucose monitoring systems are significantly more expensive than basic blood glucose meters posing an adoption challenge in price sensitive regions. Devices need to be made more affordable through cost reductions.

- System complexities: complicated setup and calibration requirements of some advanced diabetes devices poses user inconvenience. Simplified user interfaces are needed to encourage uptake among elderly populations.
Segment Analysis

The dominant sub segment in the Diabetes Monitoring Devices Market is glucose monitoring devices. This sub segment holds a largest share in the market currently due to the high adoption rate of self/home blood glucose monitors by diabetic patients. Self/home blood glucose monitors help diabetic patients frequently check their blood glucose levels at home with just a small drop of blood, allowing for better management of blood sugar levels and health outcomes.

Other major sub segments include continuous glucose monitoring devices, haemoglobin A1c testing devices and lancets & lancing devices. Continuous glucose monitoring devices are gaining traction in the market due to their advantages of constant monitoring of glucose levels through interstitial fluid. Haemoglobin A1c testing devices are also gaining demand for periodic monitoring of average blood glucose levels over past 3 months.

Global Analysis

The North America region currently dominates the Diabetes Monitoring Devices Market globally, primarily due to the rising prevalence of diabetes in the region along with faster adoption of technologically advanced diabetes devices. The presence of major players in the region along with favourable reimbursement policies are further aiding the market growth. The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to huge patient population, increasing awareness levels regarding diabetes management and rapidly developing healthcare infrastructure in developing countries such as India and China. Penetration of medical devices companies and launch of affordable diabetes monitoring products are further expected to fuel the growth of Asia Pacific Diabetes Monitoring Devices Market.

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more